- Home
- LRMR vs AEF Comparison
LRMR vs AEF Comparison
Compare LRMR & AEF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LRMR
- AEF
- Stock Information
- Founded
- LRMR N/A
- AEF 1989
- Country
- LRMR United States
- AEF United States
- Employees
- LRMR N/A
- AEF N/A
- Industry
- LRMR Biotechnology: Pharmaceutical Preparations
- AEF Finance/Investors Services
- Sector
- LRMR Health Care
- AEF Finance
- Exchange
- LRMR Nasdaq
- AEF Nasdaq
- Market Cap
- LRMR 309.8M
- AEF 264.3M
- IPO Year
- LRMR N/A
- AEF N/A
- Fundamental
- Price
- LRMR $4.13
- AEF $6.59
- Analyst Decision
- LRMR Strong Buy
- AEF
- Analyst Count
- LRMR 7
- AEF 0
- Target Price
- LRMR $16.71
- AEF N/A
- AVG Volume (30 Days)
- LRMR 5.0M
- AEF 92.5K
- Earning Date
- LRMR 11-14-2025
- AEF 01-01-0001
- Dividend Yield
- LRMR N/A
- AEF 7.13%
- EPS Growth
- LRMR N/A
- AEF N/A
- EPS
- LRMR N/A
- AEF 0.57
- Revenue
- LRMR N/A
- AEF N/A
- Revenue This Year
- LRMR N/A
- AEF N/A
- Revenue Next Year
- LRMR N/A
- AEF N/A
- P/E Ratio
- LRMR N/A
- AEF $8.86
- Revenue Growth
- LRMR N/A
- AEF N/A
- 52 Week Low
- LRMR $1.61
- AEF $4.40
- 52 Week High
- LRMR $9.50
- AEF $5.53
- Technical
- Relative Strength Index (RSI)
- LRMR 47.65
- AEF 59.86
- Support Level
- LRMR $3.88
- AEF $6.26
- Resistance Level
- LRMR $4.53
- AEF $6.67
- Average True Range (ATR)
- LRMR 0.42
- AEF 0.10
- MACD
- LRMR -0.06
- AEF 0.00
- Stochastic Oscillator
- LRMR 51.10
- AEF 80.32
About LRMR Larimar Therapeutics Inc.
Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using its novel cell-penetrating peptide (CPP) technology platform. Its lead product candidate, CTI-1601, is a subcutaneously administered, recombinant fusion protein intended to deliver human frataxin (FXN) an essential protein, to the mitochondria of patients with Friedreich's ataxia.
About AEF abrdn Emerging Markets Equity Income Fund Inc.
ABERDEEN EMERGING MARKETS EQUITY INCOME FUND, INC. is a closed-end investment company. The Fund's investment objective is to seek to provide both current income and long-term capital appreciation. The Fund invests in a range of sectors, including financials, consumer staples, utilities, consumer discretionary, materials, energy, information technology, private equity, communication services, healthcare, real estate, and industrials.